Evidence map›Paper›PMID 31908604›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice.

Marta Bonet, Virginia García, Núria Farré, Manel Algara, Blanca Farrús, Jaume Fernandez, Victoria Reyes, Arancha Eraso, Ana Álvarez, Maria José Cambra and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 2 countries.

Marta BonetDepartment of Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Virginia GarcíaDepartment of Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Núria FarréDepartment of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Manel AlgaraDepartment of Radiation Oncology, Parc de Salut Mar, Barcelona, Spain.
Blanca FarrúsDepartment of Radiation Oncology, Hospital Clínic, Barcelona, Spain.
Jaume FernandezDepartment of Radiation Oncology, Hospital Quirón, Barcelona, Spain.
Victoria ReyesDepartment of Radiation Oncology, Hospital de la Vall d'Hebron, Barcelona, Spain.
Arancha ErasoDepartment of Radiation Oncology, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain.
Ana ÁlvarezDepartment of Radiation Oncology, Institut Català d'Oncologia - Hospital Germans Trias i Pujol, Badalona, Spain.
Maria José CambraHospital General de Catalunya, Institut Oncològic del Vallès, Sant Cugat, Spain.
Agustí PedroDepartment of Radiation Oncology, Hospital Plató, Barcelona, Spain.
Jordi VayredaDepartment of Radiation Oncology, Institut Català d'Oncologia - Hospital Josep Trueta, Girona, Spain.
Claire LemanskyDepartment of Radiation Oncology, Institut de Cancérologie de Montpellier - Val d'Aurelle, University of Montpellier, France.
Françoise IzarDepartment of Radiation Oncology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
Meritxell ArenasDepartment of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Tarragona, Spain.
Grup Oncològic Català Occità (GOCO Group)
Institut Català d'Oncologia · ESHospital Universitari Arnau de Vilanova · ESHospital Clínic de Barcelona · ESHospital de Sant Pau · ESHospital General de Catalunya · ESHospital Plató · ESHospital Quirónsalud Barcelona · ESHospital Universitari Sant Joan de Reus · ESParc de Salut · ESUniversité de Montpellier · FRVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe role of radiation therapy (RT) for patients with bone-only metastatic (BOM) breast cancer has not been investigated sufficiently. The aim of this survey was to evaluate current clinical practice in treating breast cancer patients with BOM in Radiation Therapy Departments in Catalonia and Occitania within the scope of the GOCO group. MATERIALS AND

methodsAn electronic questionnaire was completed by experienced radiation oncologists from fourteen RT centers. The items surveyed the professional experience, therapeutic approach, technique, dose stereotactic body RT (SBRT) availability.

resultsAll Radiation Oncology Departments (ROD) in Catalonia (12) and Occitania (2) responded to the survey. Eleven (78.5%) of the RODs advise RT for BOM as initial treatment in the oligometastatic setting. RT to asymptomatic bone oligometastases is more often restricted for "risky lesions". The most inconsistent approaches were the treatment for asymptomatic lesions, when to treat bone metastases with respect to systemic treatment (ST) and the indication for RT after a complete response to ST.

conclusionWhile BOM breast cancer patients have a relatively good prognosis, there is a lack of consistency in their approach with RT. This can be explained by the absence of evidence-based guidelines and an incomplete availability of SBRT.

Indexed as

Bone metastasesBreast cancerOligometastasesRadiation therapySBRT

Identifiers

PMID31908604
PMCPMC6938868
OpenAlexW2995625751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.